ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABAX Abaxis, Inc. (delisted)

83.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Abaxis, Inc. (delisted) NASDAQ:ABAX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 83.00 82.85 83.01 0 01:00:00

Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2014 Animal & Dental Summit

05/12/2014 1:00pm

PR Newswire (US)


Abaxis, Inc. (delisted) (NASDAQ:ABAX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Abaxis, Inc. (delisted) Charts.

UNION CITY, Calif., Dec. 5, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood instrumentation and consumables to the medical, research and veterinary markets, announced today that Craig Tockman, DVM, Vice President of Animal Health Sales and Marketing, will present at the Bank of America Merrill Lynch 2014 Animal & Dental Summit on Thursday, December 11, 2014 at 3:35 p.m. ET. The conference will be held at the Bank of America Conference Center in Boston, MA.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.  For more information, visit http://www.abaxis.com.

Contact:

Clint Severson

Lytham Partners, LLC


Chief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum


ABAXIS, Inc

602-889-9700


510-675-6500

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-bank-of-america-merrill-lynch-2014-animal--dental-summit-300005409.html


SOURCE Abaxis, Inc.

Copyright 2014 PR Newswire

1 Year Abaxis, Inc. (delisted) Chart

1 Year Abaxis, Inc. (delisted) Chart

1 Month Abaxis, Inc. (delisted) Chart

1 Month Abaxis, Inc. (delisted) Chart

Your Recent History

Delayed Upgrade Clock